Cargando…

Physical therapies as an adjunct to Botulinum toxin-A injection of the upper or lower limb in adults following neurological impairment

BACKGROUND: Spasticity of muscles is a common consequence of central nervous system impairment. Traditionally, neurological rehabilitation for spasticity has involved occupational and physical therapy; however, increasingly Botulinum toxin–A injections may be provided. Injection effects are temporar...

Descripción completa

Detalles Bibliográficos
Autor principal: Kinnear, Bianca Z
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3434053/
https://www.ncbi.nlm.nih.gov/pubmed/22734503
http://dx.doi.org/10.1186/2046-4053-1-29
_version_ 1782242381768163328
author Kinnear, Bianca Z
author_facet Kinnear, Bianca Z
author_sort Kinnear, Bianca Z
collection PubMed
description BACKGROUND: Spasticity of muscles is a common consequence of central nervous system impairment. Traditionally, neurological rehabilitation for spasticity has involved occupational and physical therapy; however, increasingly Botulinum toxin–A injections may be provided. Injection effects are temporary. Consequently, understanding the effect of adjunct physical therapies will help inform multimodal rehabilitation decisions. Presently, these effects are not known. This systematic review will identify and summarize evidence on physical therapies used after Botulinum toxin-A injection to improve motor function in adults with neurological impairments. METHOD: Systematic searching of seven electronic databases will occur to identify relevant randomized trials. Available trial data will be extracted into a list of pre-defined primary outcomes, including range of movement, spasticity and functional limb use. Pre-defined secondary outcomes will also be reviewed where trials have these data available for reporting. Effects will be expressed as mean differences or standardized mean differences with 95% confidence intervals (CI). Where possible, comparable results will be meta-analyzed, and a summary of the available pool of evidence produced. All randomized controlled trials will be rated using the PEDro methodological quality scale. Where possible, study data will be meta-analyzed using RevMan 5 Software. The protocol was registered in PROSPERO international prosepective register of systematic reviews (PROSPERO 2011:CRD42011001491). DISCUSSION: Review results will be the most comprehensive answer available to the following question: Are physical therapies clinically effective after Botulinum toxin-A injections in adults with neurological spasticity? Results will inform healthcare providers and managers who determine who gets access to and provision of Botulinum toxin-A injection and whether this is done with or without physical therapies. Results will inform the clinicians who conduct physical therapy following injection. This protocol provides readers with the scope and depth of a search that will ultimately answer a complex and pressing treatment question. The variability of current practice and high level of expense associated with multimodal rehabilitation means review results will be more useful and less contestable if the protocol is revealed in full through advance publication.
format Online
Article
Text
id pubmed-3434053
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34340532012-09-06 Physical therapies as an adjunct to Botulinum toxin-A injection of the upper or lower limb in adults following neurological impairment Kinnear, Bianca Z Syst Rev Protocol BACKGROUND: Spasticity of muscles is a common consequence of central nervous system impairment. Traditionally, neurological rehabilitation for spasticity has involved occupational and physical therapy; however, increasingly Botulinum toxin–A injections may be provided. Injection effects are temporary. Consequently, understanding the effect of adjunct physical therapies will help inform multimodal rehabilitation decisions. Presently, these effects are not known. This systematic review will identify and summarize evidence on physical therapies used after Botulinum toxin-A injection to improve motor function in adults with neurological impairments. METHOD: Systematic searching of seven electronic databases will occur to identify relevant randomized trials. Available trial data will be extracted into a list of pre-defined primary outcomes, including range of movement, spasticity and functional limb use. Pre-defined secondary outcomes will also be reviewed where trials have these data available for reporting. Effects will be expressed as mean differences or standardized mean differences with 95% confidence intervals (CI). Where possible, comparable results will be meta-analyzed, and a summary of the available pool of evidence produced. All randomized controlled trials will be rated using the PEDro methodological quality scale. Where possible, study data will be meta-analyzed using RevMan 5 Software. The protocol was registered in PROSPERO international prosepective register of systematic reviews (PROSPERO 2011:CRD42011001491). DISCUSSION: Review results will be the most comprehensive answer available to the following question: Are physical therapies clinically effective after Botulinum toxin-A injections in adults with neurological spasticity? Results will inform healthcare providers and managers who determine who gets access to and provision of Botulinum toxin-A injection and whether this is done with or without physical therapies. Results will inform the clinicians who conduct physical therapy following injection. This protocol provides readers with the scope and depth of a search that will ultimately answer a complex and pressing treatment question. The variability of current practice and high level of expense associated with multimodal rehabilitation means review results will be more useful and less contestable if the protocol is revealed in full through advance publication. BioMed Central 2012-06-26 /pmc/articles/PMC3434053/ /pubmed/22734503 http://dx.doi.org/10.1186/2046-4053-1-29 Text en Copyright ©2012 Kinnear; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Protocol
Kinnear, Bianca Z
Physical therapies as an adjunct to Botulinum toxin-A injection of the upper or lower limb in adults following neurological impairment
title Physical therapies as an adjunct to Botulinum toxin-A injection of the upper or lower limb in adults following neurological impairment
title_full Physical therapies as an adjunct to Botulinum toxin-A injection of the upper or lower limb in adults following neurological impairment
title_fullStr Physical therapies as an adjunct to Botulinum toxin-A injection of the upper or lower limb in adults following neurological impairment
title_full_unstemmed Physical therapies as an adjunct to Botulinum toxin-A injection of the upper or lower limb in adults following neurological impairment
title_short Physical therapies as an adjunct to Botulinum toxin-A injection of the upper or lower limb in adults following neurological impairment
title_sort physical therapies as an adjunct to botulinum toxin-a injection of the upper or lower limb in adults following neurological impairment
topic Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3434053/
https://www.ncbi.nlm.nih.gov/pubmed/22734503
http://dx.doi.org/10.1186/2046-4053-1-29
work_keys_str_mv AT kinnearbiancaz physicaltherapiesasanadjuncttobotulinumtoxinainjectionoftheupperorlowerlimbinadultsfollowingneurologicalimpairment